IE
EDIT icon

Israel Englander’s Editas Medicine EDIT Stock Holding History

Israel Englander’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50,000
Closed -$2.05M – 6928
2021
Q3 		$2.05M Buy
+50,000
New +$2.74M ﹤0.01% 3880

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Israel Englander's EDIT Position: Q2 2026 in Review

Israel Englander opened a new position in Editas Medicine (EDIT) in Q2 2026: 498,997 shares worth $1.62M. The stake represents ﹤0.01% of the portfolio and ranks #3980 among its holdings. This is a return to the name: Israel Englander previously reported a position in EDIT as recently as Q4 2025.

Israel Englander first reported a position in EDIT in Q2 2016 and has held it in 36 quarters since. The position peaked at $26.2M in Q4 2021. 213 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Israel Englander held 498,997 shares of Editas Medicine worth $1.62M as of Q2 2026.
  • Editas Medicine was a new Israel Englander position in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3980 holding.
  • Israel Englander first reported a position in Editas Medicine in Q2 2016 and has held it in 36 quarters since.
  • Israel Englander's Editas Medicine position peaked at $26.2M in Q4 2021.
  • 213 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.